December 2017 FDA Recall Drug by Solco Healtcare Us Llc
D-0155-2018 - Labeling
This Class II drug recall was voluntarily initiated by Solco Healtcare Us Llc on December 4, 2017 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed in Product was distributed in Mason, OH. and the recall is currently terminated.
Recall Number: D-0155-2018
Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg
12-04-2017
01-17-2018
N/A
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Solco Healtcare US LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Product was distributed in Mason, OH.
02-25-2019
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50
Batch or Lot Expiration Information
Lot# 7700656A